Paul Tudor Jones Biogen Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Biogen Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 53,711 shares of BIIB stock, worth $8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

53,711

Previous 8,668 519.65%

Holding current value

$8 Million

Previous $2.01 Million 418.22%

% of portfolio

0.04%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $8.52 Million - $10.7 Million	45,043 Added 519.65%	53,711 $10.4 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $6.93 Million - $8.61 Million	-36,374 Reduced 80.76%	8,668 $2.01 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $9.55 Million - $12.1 Million	45,042 New	45,042 $9.71 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $1.15 Million - $1.39 Million	-4,548 Reduced 47.66%	4,995 $1.38 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.52 Million - $2.1 Million	7,810 Added 450.66%	9,543 $2.55 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $611,192 - $726,822	-3,259 Reduced 65.28%	1,733 $353,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $967,299 - $1.22 Million	4,992 New	4,992 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $1.92 Million - $2.47 Million	-8,595 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.3 Million - $1.7 Million	4,606 Added 115.47%	8,595 $2.43 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $1.03 Million - $1.65 Million	3,989 New	3,989 $1.38 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $835,262 - $978,557	-3,438 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $812,261 - $1.22 Million	3,438 New	3,438 $842,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $1.28 Million - $1.47 Million	-4,820 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $124,674 - $165,109	482 Added 11.11%	4,820 $1.29 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $158,621 - $201,213	590 Added 15.74%	4,338 $1.37 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $10.8 Million - $14.9 Million	-48,931 Reduced 92.89%	3,748 $1.11 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $4.18 Million - $4.69 Million	19,242 Added 57.55%	52,679 $12.3 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $1.51 Million - $1.66 Million	-6,874 Reduced 17.05%	33,437 $7.82 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $3.38 Million - $5.29 Million	15,601 Added 63.14%	40,311 $9.53 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $1.74 Million - $2.2 Million	6,248 Added 33.84%	24,710 $7.44 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $3.19 Million - $4.17 Million	10,871 Added 143.21%	18,462 $6.52 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $502,936 - $599,395	1,953 Added 34.64%	7,591 $2.2 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $594,136 - $840,306	2,284 Added 68.1%	5,638 $1.54 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $1.03 Million - $1.16 Million	3,354	3,354 $1.07 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account